Immunology and Microbiology
Cancer Cell
100%
Ecalectin
92%
T Cell
85%
Antineoplastic Activity
61%
Granulocyte
49%
CD20
46%
CD47
46%
Macrophage
44%
Neutrophil Granulocyte
42%
Bispecific Antibody
40%
Phagocytosis
39%
Calreticulin
39%
CXCL16
37%
Neutrophil
37%
Myeloid
37%
Cytotoxicity
33%
Autoimmunity
30%
Epidermal Growth Factor
27%
Immunotherapy
27%
Cell Phagocytosis
24%
Endoplasmic reticulum
24%
Monospecific Antibody
24%
TNF related apoptosis inducing ligand
22%
Inflammatory Arthritis
22%
Cell Surface
22%
Tumor Immunity
21%
CXCR6
21%
Cancer Immunotherapy
21%
Rituximab
21%
Autophagy
20%
Tumor Necrosis Factor
20%
Promoter Region
18%
Therapeutic Antibodies
18%
T Helper 1 Cell
18%
Glycation
18%
Arginine Deiminase
18%
Obinutuzumab
18%
C-Type Lectin
18%
Immunopathology
18%
Alemtuzumab
18%
Antibody-Dependent Cell-Mediated Cytotoxicity
18%
Daratumumab
18%
Isoetarine
18%
Concanavalin A
18%
Surface Property
17%
B Cell
17%
Cetuximab
16%
Innate Immune System
15%
Monoclonal Antibody
15%
Trogocytosis
14%
Biochemistry, Genetics and Molecular Biology
Autophagy
79%
Galectin
68%
Cancer Cell
63%
Antineoplastic Activity
61%
Tumor Necrosis Factor
48%
Anticancer
41%
Myeloid
38%
Cytarabine
37%
Calreticulin
37%
Neutrophil Granulocyte
37%
TRAIL
37%
Cancer Immunotherapy
37%
Cell Death
31%
T Cell
27%
Cytotoxicity
26%
Surface Property
24%
Immune Response
21%
Eicosanoid Receptor
20%
Formyl Peptide Receptor
18%
Lipopolysaccharide
18%
Advanced Glycation End-Product
18%
Gene Expression
18%
Tumor Immunity
18%
Epithelial Polarity
18%
Therapeutic Antibodies
18%
Granulocyte
18%
KRAS
18%
C-Type Lectin
18%
Antibody Dependent Cellular Cytotoxicity
18%
Colon
18%
Lectin
18%
Cytarabine
18%
Fusion Protein
16%
Immunocompetent Cell
13%
Allele
12%
Concanavalin A
12%
Cigarette Smoking
8%
Monoclonal Antibody
8%
Tumor Progression
6%
Signal Transduction
6%
Single Nucleotide Polymorphism
6%
Downregulation
6%
Genetics
6%
CRISPR/Cas9
6%
Differential Gene Expression
6%
Innate Immunity
6%
Phagocytosis
5%
Autophagosome
5%
Natural Killer Cell
5%
Medicine and Dentistry
Malignant Neoplasm
85%
Antineoplastic Activity
59%
Cancer Cell
49%
T Cell
46%
Cell Surface
39%
Proteinase
37%
Ovarian Cancer
37%
Autophagy
37%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
27%
Bispecific Antibody
27%
Autoimmunity
27%
Cancer Immunotherapy
25%
Neoplasm
24%
Phagocytosis
23%
Cancer Therapy
22%
Endoplasmic reticulum
22%
Tumor Immunity
21%
Calreticulin
20%
Monoclonal Antibody
19%
Antibody Dependent Cellular Cytotoxicity
18%
Epidermal Growth Factor Receptor
18%
Neutrophil
18%
Granulocyte
18%
Lectin
18%
Targeted Therapy
18%
Cytarabine
18%
Leukemia Cell
18%
Acute Myeloid Leukemia
18%
Prospective Study
18%
Hyperglycemia
18%
Rituximab
17%
Immune Response
14%
In Vitro
14%
Cytotoxicity
14%
Chaperone
13%
Cell Migration
13%
Enzyme Linked Immunosorbent Assay
13%
Co-Stimulation
12%
Cetuximab
12%
Autoimmune Disease
11%
Disease
11%
Lymphocytic Infiltration
9%
Immunocytokine
9%
Fusion Protein
9%
Chimeric Antigen Receptor
9%
Tumor Necrosis Factor Alpha Converting Enzyme
9%
T-Cell Response
9%
Nodular Melanoma
9%
Inflammatory Disorder
9%
Recombinant DNA
9%